Literature DB >> 19327846

HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.

Kerstin Imrell1, Eva Greiner, Jan Hillert, Thomas Masterman.   

Abstract

Carriage of HLA-DRB1*15 is the most important genetic risk factor in multiple sclerosis (MS), while CSF-specific oligoclonal immunoglobulin G bands (OCB) constitute the most sensitive biochemical marker for diagnosing MS. We demonstrated in an earlier study the interdependence of HLA-DRB1 genotype and OCB status; the effect of these phenotypic features on MS prognosis remains controversial, however. We investigated by survival analysis the impact of each variable on age at two important MS milestones: onset of clinical symptoms and an Expanded Disability Status Scale (EDSS) score of 6.0. Both carriage of HLA-DRB1*15 and the presence of OCB hastened attainment of EDSS 6.0.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327846     DOI: 10.1016/j.jneuroim.2009.03.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Sex and gender issues in multiple sclerosis.

Authors:  Hanne F Harbo; Ralf Gold; Mar Tintoré
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

3.  Evaluating the Role of HLA DRB1 Alleles and Oligoclonal Bands in Influencing Clinical Course of Multiple Sclerosis - A Study from the Mangalore Demyelinating Disease Registry.

Authors:  Anitha DCunha; Lekha Pandit; Chaithra Malli; Akshatha Sudhir
Journal:  Ann Indian Acad Neurol       Date:  2021-01-11       Impact factor: 1.383

4.  Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.

Authors:  Hanne F Harbo; Noriko Isobe; Pål Berg-Hansen; Steffan D Bos; Stacy J Caillier; Marte W Gustavsen; Inger-Lise Mero; Elisabeth Gulowsen Celius; Stephen L Hauser; Jorge R Oksenberg; Pierre-Antoine Gourraud
Journal:  Mult Scler       Date:  2013-10-07       Impact factor: 6.312

Review 5.  The evidence for a role of B cells in multiple sclerosis.

Authors:  G Disanto; J M Morahan; M H Barnett; G Giovannoni; S V Ramagopalan
Journal:  Neurology       Date:  2012-03-13       Impact factor: 9.910

6.  No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Authors:  Madlyne Becker; Clotilde Latarche; Emilie Roman; Marc Debouverie; Catherine Malaplate-Armand; Francis Guillemin
Journal:  BMC Neurol       Date:  2015-05-13       Impact factor: 2.474

7.  Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.

Authors:  Inger-Lise Mero; Marte W Gustavsen; Hanne S Sæther; Siri T Flåm; Pål Berg-Hansen; Helle B Søndergaard; Poul Erik H Jensen; Tone Berge; Anja Bjølgerud; Aslaug Muggerud; Jan H Aarseth; Kjell-Morten Myhr; Elisabeth G Celius; Finn Sellebjerg; Jan Hillert; Lars Alfredsson; Tomas Olsson; Annette Bang Oturai; Ingrid Kockum; Benedicte A Lie; Bettina Kulle Andreassen; Hanne F Harbo
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

8.  An Intergenic rs9275596 Polymorphism on Chr. 6p21 Is Associated with Multiple Sclerosis in Latvians.

Authors:  Natalia Paramonova; Ilva Trapina; Kristine Dokane; Jolanta Kalnina; Tatjana Sjakste; Nikolajs Sjakste
Journal:  Medicina (Kaunas)       Date:  2020-03-31       Impact factor: 2.430

9.  Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands.

Authors:  Lin Zhao; Jill Abrigo; Qianyun Chen; Cheryl Au; Angel Ng; Ping Fan; Vincent Mok; Wei Qiu; Allan G Kermode; Alexander Y Lau
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.